173 related articles for article (PubMed ID: 36106216)
1. Clinically Amyopathic Dermatomyositis With Rapid Progressive Interstitial Lung Disease Diagnosed in a Patient on Extracorporeal Membrane Oxygenation.
Al-Husayni F; Munshi A; Qanash S; Shaikhain TA; Alzahrani Z; Alghamdi B
Cureus; 2022 Aug; 14(8):e27839. PubMed ID: 36106216
[TBL] [Abstract][Full Text] [Related]
2. Case Report: Extracorporeal Membrane Oxgenation for Rapidly Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis in a Post-partum Woman.
Gu Q; Diao M; Hu W; Huang M; Zhu Y
Front Med (Lausanne); 2021; 8():742823. PubMed ID: 34660647
[No Abstract] [Full Text] [Related]
3. Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review.
McPherson M; Economidou S; Liampas A; Zis P; Parperis K
Semin Arthritis Rheum; 2022 Apr; 53():151959. PubMed ID: 35134633
[TBL] [Abstract][Full Text] [Related]
4. Combined usage of extracorporeal membrane oxygenation and double filtration plasmapheresis in amyopathic dermatomyositis patient with severe interstitial lung disease: A case report.
Huang J; Liu C; Zhu R; Su Y; Lin J; Lu J; Wen S; Zuo L
Medicine (Baltimore); 2018 Jun; 97(22):e10946. PubMed ID: 29851838
[TBL] [Abstract][Full Text] [Related]
5. Anti-MDA5 antibody-positive rapidly progressive interstitial pneumonia without cutaneous manifestations.
Aoyama J; Hayashi H; Yajima C; Takoi H; Tanaka T; Kashiwada T; Kokuho N; Terasaki Y; Nishikawa A; Gono T; Kuwana M; Saito Y; Abe S; Seike M; Gemma A
Respir Med Case Rep; 2019; 26():193-196. PubMed ID: 30723666
[TBL] [Abstract][Full Text] [Related]
6. Respiratory symptoms as initial manifestations of interstitial lung disease in clinically amyopathic juvenile dermatomyositis: a case report with literature review.
Xia J; Jiang G; Jin T; Shen Q; Ma Y; Wang L; Qian L
BMC Pediatr; 2021 Nov; 21(1):488. PubMed ID: 34732158
[TBL] [Abstract][Full Text] [Related]
7. A Japanese-American female with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis.
Takada T; Asakawa K; Barrios R
Clin Rheumatol; 2021 Mar; 40(3):1159-1165. PubMed ID: 32676922
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report.
Cao M; Zhang S; Chu D; Xiao M; Liu X; Yu L; Li J; Huang Y; Fang F
BMC Pulm Med; 2020 Nov; 20(1):304. PubMed ID: 33213393
[TBL] [Abstract][Full Text] [Related]
9. Lung histopathological pattern in a survivor with rapidly progressive interstitial lung disease and anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis.
Suzuki A; Kondoh Y; Taniguchi H; Tabata K; Kimura T; Kataoka K; Ono K; Hashisako M; Fukuoka J
Respir Med Case Rep; 2016; 19():5-8. PubMed ID: 27354955
[TBL] [Abstract][Full Text] [Related]
10. Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review.
Nishi K; Ogura M; Tamai N; Gima M; Ide K; Koinuma G; Kamei K; Ito S
Pediatr Rheumatol Online J; 2022 Aug; 20(1):60. PubMed ID: 35927666
[TBL] [Abstract][Full Text] [Related]
11. Correlation between disease activity and serum ferritin in clinically amyopathic dermatomyositis with rapidly-progressive interstitial lung disease: a case report.
Yamada K; Asai K; Okamoto A; Watanabe T; Kanazawa H; Ohata M; Ohsawa M; Hirata K
BMC Res Notes; 2018 Jan; 11(1):34. PubMed ID: 29338781
[TBL] [Abstract][Full Text] [Related]
12. Rapidly progressive interstitial lung disease due to anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis complicated with cervical cancer: Successful treatment with direct hemoperfusion using polymyxin B-immobilized fiber column therapy.
Ichiyasu H; Sakamoto Y; Yoshida C; Sakamoto K; Fujita R; Nakayama G; Okabayashi H; Saeki S; Okamoto S; Kohrogi H
Respir Med Case Rep; 2017; 20():51-54. PubMed ID: 27995057
[TBL] [Abstract][Full Text] [Related]
13. Progressive interstitial lung disease in hypomyopathic dermatomyositis in the COVID-19 pandemic: A case report.
Wang S; Lyu Y; Xu L; Zhang W
Int J Rheum Dis; 2023 Apr; 26(4):759-763. PubMed ID: 36502514
[TBL] [Abstract][Full Text] [Related]
14. Anti-MDA5 antibody-positive clinically amyopathic dermatomyositis with diffuse alveolar damage diagnosed by transbronchial lung cryobiopsy: A case report.
Ishihara H; Kataoka K; Takei R; Yamano Y; Yokoyama T; Matsuda T; Kimura T; Fukuoka J; Johkoh T; Kondoh Y
Respirol Case Rep; 2021 Nov; 9(11):e0865. PubMed ID: 34707877
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis.
Xu Y; Yang CS; Li YJ; Liu XD; Wang JN; Zhao Q; Xiao WG; Yang PT
Clin Rheumatol; 2016 Jan; 35(1):113-6. PubMed ID: 26660480
[TBL] [Abstract][Full Text] [Related]
16. Successful polymyxin B hemoperfusion treatment associated with serial reduction of serum anti-CADM-140/MDA5 antibody levels in rapidly progressive interstitial lung disease with amyopathic dermatomyositis.
Teruya A; Kawamura K; Ichikado K; Sato S; Yasuda Y; Yoshioka M
Chest; 2013 Dec; 144(6):1934-1936. PubMed ID: 24297126
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD
J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
[TBL] [Abstract][Full Text] [Related]
18. Early initiation of plasma exchange therapy for a patient with anti-MDA5 autoantibody-positive dermatomyositis developing rapidly progressive interstitial lung disease.
Sasaki N; Ishii A; Kurabayashi T; Sugiyama M; Izumi Y; Nakagome Y; Hirano K; Sasaki S; Kondo Y; Nogi S; Nishikawa A; Hosono Y; Yamada C; Sato S
Mod Rheumatol Case Rep; 2021 Jan; 5(1):87-94. PubMed ID: 33048020
[TBL] [Abstract][Full Text] [Related]
19. Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?
Ikeda S; Arita M; Morita M; Ikeo S; Ito A; Tokioka F; Noyama M; Misaki K; Notohara K; Ishida T
BMC Pulm Med; 2015 Dec; 15():159. PubMed ID: 26651481
[TBL] [Abstract][Full Text] [Related]
20. A case of sarcoidosis with interstitial lung disease mimicking clinically amyopathic dermatomyositis and rapidly progressive interstitial lung disease.
Sato S; Nogi S; Sasaki N; Chinen N; Honda K; Saito E; Wakabayashi T; Yamada C; Suzuki Y
Case Rep Rheumatol; 2014; 2014():195617. PubMed ID: 25431723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
